Teleflex Incorporated (NYSE:TFX) Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. reduced its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 52.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 19,635 shares of the medical technology company's stock after selling 22,091 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Teleflex were worth $2,713,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in TFX. Intact Investment Management Inc. bought a new position in Teleflex during the first quarter worth about $69,000. Praxis Investment Management Inc. acquired a new stake in shares of Teleflex during the first quarter worth about $345,000. State of Alaska Department of Revenue lifted its stake in Teleflex by 386.0% in the first quarter. State of Alaska Department of Revenue now owns 25,734 shares of the medical technology company's stock valued at $3,556,000 after buying an additional 20,439 shares in the last quarter. QRG Capital Management Inc. boosted its holdings in shares of Teleflex by 35.9% in the first quarter. QRG Capital Management Inc. now owns 2,959 shares of the medical technology company's stock valued at $409,000 after buying an additional 781 shares during the period. Finally, Janney Montgomery Scott LLC increased its position in shares of Teleflex by 5.6% during the first quarter. Janney Montgomery Scott LLC now owns 17,665 shares of the medical technology company's stock worth $2,441,000 after acquiring an additional 942 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on TFX shares. Wall Street Zen cut Teleflex from a "buy" rating to a "hold" rating in a research report on Sunday. Truist Financial lowered their target price on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research note on Monday, May 5th. Morgan Stanley cut their price target on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Wells Fargo & Company reduced their price target on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, May 2nd. Finally, Royal Bank Of Canada lowered their target price on Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a research note on Friday, May 2nd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $164.63.

Teleflex Trading Down 0.4%

Shares of Teleflex stock traded down $0.43 during midday trading on Wednesday, reaching $121.40. 532,467 shares of the company's stock traded hands, compared to its average volume of 629,676. The stock has a 50 day moving average of $123.99 and a 200-day moving average of $146.72. Teleflex Incorporated has a 12 month low of $115.94 and a 12 month high of $249.91. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.32 and a current ratio of 2.28. The company has a market cap of $5.36 billion, a PE ratio of 38.30, a price-to-earnings-growth ratio of 1.85 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The business's revenue for the quarter was down 5.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.21 earnings per share. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date of this dividend was Tuesday, May 20th. Teleflex's dividend payout ratio (DPR) is currently 42.90%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.